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Abstract
Background: Cannabis, or Marijuana, remains one of the most universally used recreational drugs.
Over the last four decades, its popularity has risen considerably as it became easily accessible and
relatively affordable. Peak use is amongst the young aged 18 to 25 years, although these figures are
now shifting towards earlier teens. A strongly installed culture still regards cannabis a harmless
drug, yet as more reports have shown there are considerable adverse cardiovascular events linked
with its use.
Case Presentation: In this paper, we present the case of a 15-year-old male who suffered a
cardiac arrest following cannabis use and survived the episode.
Conclusion: Cardiac arrest is a rare and possibly fatal consequence of cannabis use. Public
awareness should be raised by extensively promoting all potential complications associated with its
use.
Introduction
The recreational use of cannabis, or marijuana, has been
on the rise since the 1960s. Its popularity has been cata-
lysed by an easy accessibility and affordability. Peak use is
generally amongst the young aged 18 to 25 years [1-3],
although these figures are now shifting towards earlier
teens [2]. Nevertheless, a strongly installed culture still
regards cannabis harmless when compared to other exist-
ing illicit drugs [1]. As more reports have shown, there are
considerable adverse cardiovascular events linked with its
use.
Case Report
A 15-year-old English Caucasian male was brought to our
emergency department having suffered a witnessed car-
diac arrest, following the use of alcohol and cannabis with
friends. Paramedics attended the scene within three min-
utes of call being passed: cardiopulmonary resuscitation
(CPR) was in progress by the patient's friends, and the first
recorded rhythm was asystole. After two minutes of CPR,
the rhythm changed into ventricular fibrillation (VF)
which was successfully cardioverted into a sinus rhythm
with a single DC shock (200 J).
On arrival to hospital, the patient was maintaining his air-
way with respiratory arrhythmia. His vital signs showed a
blood pressure (BP) of 115/86, a heart rate (HR) of 86
bpm and a recorded GCS of 4 out of 15. In view of the res-
piratory arrhythmia and impaired GCS, he was intubated
and ventilated.
Investigations conducted in the emergency department
showed the initial 12-lead electrocardiogram (ECG) to be
in a normal sinus rhythm without any acute ischaemia.
No changes were identified on subsequent 12-lead ECGs.
Urine drug screen (Princeton BioMeditech Corp., Accu-
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Sign® DOA 4) was positive for THC, but negative for opi-
ates, amphetamines and cocaine. Blood tests including
haematology, biochemistry and gases were all within nor-
mal.
Radiological imaging revealed normal chest X-ray and
computed tomography (CT) scan of the head. Of note, the
patient had an episode of significant bradycardia whilst
being scanned that necessitated a dose of intravenous
Atropine.
Further information obtained from social workers dis-
closed the patient to suffer from attention deficit disorder
(ADHD) along with a history of previous cocaine and
ecstasy abuse. Although Ritalin was prescribed for his
ADHD, he had failed to comply with the treatment in the
last 18 months.
Our patient was admitted to a paediatric intensive care
unit (PICU) at a neighbouring hospital. He was success-
fully extubated within 24 hours, and discharged from hos-
pital 5 days later with no neurological or cardiovascular
sequelae. Although arrangements were made for an out-
patient follow up, he failed to attend his appointments
and further cardiological assessments (such as echocardi-
ography) never materialised.
Discussion
Cannabis sativa or  marijuana, is a plant that has been
known to humankind as early as the 8th century BC in
ancient Mesopotamia [1]. It was purposely grown for its
fibres that went into the production of rope and tissues,
whereas its resin was regarded as a medication to alleviate
pain and insomnia. Cannabis was brought to Europe in
the 19th century by the returning Napoleonic soldiers
from the Middle East [4].
The resin holds more than 400 chemical compounds and
60 psychoactive materials known as cannabinoids with
the most potent agent being delta-9-tetrahydrocannabi-
nol (Δ9-THC, or simply THC) [1-5]. Progress made in agri-
cultural techniques altered the THC content and as a
result, the drug's potency was significantly enhanced. A
joint in the 1960's would have averaged 10 mg of THC
compared to 150-400 mg nowadays [2,5].
Cannabinoids, including THC, are exceptionally lipid sol-
uble; tissue distribution is proportional to blood flow
with peak accumulation in fatty tissues attained in 4 to 5
days. The plasma and tissue half-lives are around 30 hours
and 7 days respectively [2,6]. It can thus be detected in
urine samples several days after a single use or up to
months in chronic abusers [6].
In humans, the biological effects of cannabis are mediated
by two G-protein coupled receptors: CB1 and CB2. Both
have been recognized to be cannabinoid specific. The CB1
receptors, known as neuronal cannabinoid receptors, are
present mainly in the central and peripheral nervous sys-
tem, but can also be found in the lungs, kidneys and liver.
Activation of CB1  receptors inhibits the sympathetic
response causing vasodilation that consequently leads to
hypotension and bradycardia; an effect that is mediated
by the endogenous cannabinoid neurotransmitters anan-
damide (N-arachidonoylethanolamine) and 2-AG (2-ara-
chidonoylglycerol). CB2 receptors are present throughout
most of the immune system and their activation might be
implicated in nociception [1,2,5,7-9].
Cardiovascular manifestations of cannabis result from a
biphasic dose-dependent physiological effect on the auto-
nomic nervous system: low to moderate doses tend to
cause tachycardia and raised blood pressure (proportional
to an increase in cardiac output) by increasing the sympa-
thetic activity, whilst high doses produce bradycardia and
hypotension by increasing the parasympathetic activity
[1-3,5,6,8]. Myocardial tissue ischaemia secondary to can-
nabis use is thought to be resulting from one of the fol-
lowing pathophysiological factors: (1) an increase in O2
demand secondary to increased heart rate, (2) a decreased
O2 supply secondary to a rise in carboxyhaemoglobin lev-
els post smoking or (3) a reduced blood flow secondary to
arterial vasospasm.
Reported complication associated with cannabis use is
myocardial infarction. It is assumed to be an outcome of
myocardial tissue ischemia in people with either normal
or atherosclerotic coronary arteries, with the risk of infarc-
tion increasing to almost 5-fold in the first hour amongst
users [1,3,6,7]. To date, seven cases of myocardial infarc-
tion associated with cannabis use have been reported: six
were male, age ranging from 17 to 48 years (a median of
32 years), and four had normal coronary vasculature
[1,7].
Bachs and Morland [10] discussed six cases of acute cardi-
ovascular death after cannabis use. The association was
confirmed by a positive serum THC toxicology at post-
mortem: all were male aged 17 to 43 years (a median of
40 years), and four had atheromatous coronary vascula-
ture. Although similar fatal cases were also reported, the
majority lacked toxicological evidence [3,7,10].
Cannabis, in conjunction with alcohol and drugs such as
cocaine, creates a more pronounced synergetic effect on
the myocardium: it triggers a significant tachycardia that
leads to ischemia, and subsequently infarction and even
death [3,6,11]. Finally, other reported cardiovascularPublish with BioMed Central    and   every 
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complications included ventricular tachy-arrhythmias [3]
and atrial fibrillation [3,5,7,8].
In our case, two facts need to be addressed. Firstly, the can-
nabis causality was assumed on the result of the positive
urine drug screen; hence, a full toxicology screen was not
pursued. Secondly, an inpatient echocardiograph was also
not documented and later not performed as the patient
failed to attend his outpatient's follow up. We feel the
effects of chronic cannabis abuse were most likely poten-
tiated by the alcohol consumption. This could have led to
a sudden over-parasympathetic activity along with a pos-
sible tissue ischaemia, thus triggering the asystolic epi-
sode.
It is of interest to point out that there has been no report
yet in the literature stating an asystolic cardiac arrest fol-
lowing cannabis use and survival at a young age.
Conclusion
Recreational use of cannabis will remain on the rise with
a number of potentially serious, if not fatal, conse-
quences. Availability and affordability has resulted in it
being not only accessible to an adult population, but also
teenagers. Since 2004, cannabis in the UK has been classi-
fied as a 'class C' drug: a fact that is definitely carrying an
immense health implication secondary to its consump-
tion with calls already being raised to re-classify it as a
'class B'. Public awareness should be extensively made
regarding all possible complications, and emergency phy-
sicians should not assume asystolic arrest has an inevita-
ble fatal outcome.
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